JBIO – jade biosciences, inc. (US:NASDAQ)

News

Jade Biosciences (JBIO) had its "buy" rating reaffirmed by HC Wainwright.
Jade Biosciences (JBIO) was upgraded by Weiss Ratings from "sell (d-)" to "sell (d)".
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
Jade Biosciences: Caution Advised Before Clinical Trial Results [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com